New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Schanz J
  • Tüchler H
  • Solé F
  • Mallo M
  • Luño E
  • Granada I
  • Hildebrandt B
  • Slovak ML
  • Ohyashiki K
  • Steidl C
  • Fonatsch C
  • Pfeilstöcker M
  • Nösslinger T
  • Valent P
  • Giagounidis A
  • Aul C
  • Lübbert M
  • Stauder R
  • Krieger O
  • Garcia-Manero G
  • Faderl S
  • Pierce S
  • Le Beau MM
  • Bennett JM
  • Greenberg P
  • Germing U
  • Haase D

Grupos

Abstract

The karyotype is a strong independent prognostic factor in myelodysplastic syndromes (MDS). Since the implementation of the International Prognostic Scoring System (IPSS) in 1997, knowledge concerning the prognostic impact of abnormalities has increased substantially. The present study proposes a new and comprehensive cytogenetic scoring system based on an international data collection of 2,902 patients.

Datos de la publicación

ISSN/ISSNe:
0732-183X, 1527-7755

JOURNAL OF CLINICAL ONCOLOGY  AMER SOC CLINICAL ONCOLOGY

Tipo:
Article
Páginas:
820-829
PubMed:
22331955
Factor de Impacto:
9,281 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 528

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Campos de Estudio

Cita

Compartir